Broadreach Global LLC

Bio-Neuroscience 2026 Selects 12 Pioneering Companies to Present at Premier Global Neuroscience Drug Development Summit

Bio-Neuroscience today announced the selection of 12 neuroscience drug development companies to present at Bio-Neuroscience 2026, the premier global gathering of neuroscience innovation leaders, investors, and pharmaceutical executives. The companies were chosen from a competitive international field following rigorous evaluation of their scientific innovation, clinical progress, therapeutic approach, and commercial potential. - February 04, 2026